Lucio Gordan works in the field of Hematology. He received 1 awards: "CMS Meaningful Use Stage 1 Certification". Lucio Gordan is a published doctor. He has 1 paper published. The most current publication "Phase II trial of individualized rituximab dosing for patients with CD20-positive lymphoproliferative disorders." He accepts Medicare.
NPI NUMBER | 1346235975 | |
NPPES Provider LastName | GORDAN | |
NPPES Provider FirstName | LUCIO | |
NPPES Provider ZIPCode | 326054218 | |
NPPES Provider State | FL | |
Specialty Description | Hematology/Oncology | |
Total Claim Count | 1402.0 | |
Distinct Opioid Count | 5.0 | |
Opioid Claim Count | 212.0 | |
Percent Opioid Claims | 15.12 |
National Provider Identifier [NPI] | 1346235975 |
Last Name Of The Provider | GORDAN |
First Name Of The Provider | LUCIO |
View All |
Dr. Andres W. Bhatia, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Robert R. Carroll, MD | |
Dr. William L. Clapp III, MD
This Doctor is OpenDoctor Recommended. |